Scuderi, S.A.; Casili, G.; Basilotta, R.; Lanza, M.; Filippone, A.; Raciti, G.; Puliafito, I.; Colarossi, L.; Esposito, E.; Paterniti, I.
NLRP3 Inflammasome Inhibitor BAY-117082 Reduces Oral Squamous Cell Carcinoma Progression. Int. J. Mol. Sci. 2021, 22, 11108.
https://doi.org/10.3390/ijms222011108
AMA Style
Scuderi SA, Casili G, Basilotta R, Lanza M, Filippone A, Raciti G, Puliafito I, Colarossi L, Esposito E, Paterniti I.
NLRP3 Inflammasome Inhibitor BAY-117082 Reduces Oral Squamous Cell Carcinoma Progression. International Journal of Molecular Sciences. 2021; 22(20):11108.
https://doi.org/10.3390/ijms222011108
Chicago/Turabian Style
Scuderi, Sarah Adriana, Giovanna Casili, Rossella Basilotta, Marika Lanza, Alessia Filippone, Gabriele Raciti, Ivana Puliafito, Lorenzo Colarossi, Emanuela Esposito, and Irene Paterniti.
2021. "NLRP3 Inflammasome Inhibitor BAY-117082 Reduces Oral Squamous Cell Carcinoma Progression" International Journal of Molecular Sciences 22, no. 20: 11108.
https://doi.org/10.3390/ijms222011108
APA Style
Scuderi, S. A., Casili, G., Basilotta, R., Lanza, M., Filippone, A., Raciti, G., Puliafito, I., Colarossi, L., Esposito, E., & Paterniti, I.
(2021). NLRP3 Inflammasome Inhibitor BAY-117082 Reduces Oral Squamous Cell Carcinoma Progression. International Journal of Molecular Sciences, 22(20), 11108.
https://doi.org/10.3390/ijms222011108
